EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers

Eun-Hee Cho, Min Gu Kang, Chang Hun Lee, Shinyoung Oh, Chen Shen, Ha Ram Oh, Young Ran Park, Hyun Lee, Jong Seung Kim, Ji Hyun Park

Endocrinology and Metabolism · 2025

DOI: 10.3803/enm.2024.2286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endocrinology and Metabolism, 2025. Verfasst von Eun-Hee Cho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Diabetes Mellitus, Type 2, Liver Neoplasms, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 2 diabetes mellitus (T2DM) is a significant risk factor for hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease; however, surveillance strategies for patients with T2DM, especially without cirrhosis, are inadequate. This study examined whether the fatty liver index (FLI) and its dynamic changes can effectively identify patients with T2DM at increased risk for HCC.

Methods

Data from 92,761 individuals with T2DM aged 40 to 79 who underwent two health screenings (2012 to 2015) were analyzed. The FLI, calculated using waist circumference, body mass index, triglycerides, and gamma-glutamyl transferase, was used to stratify patients by baseline FLI and FLI changes between screenings. HCC cases were identified via International Classification of Diseases codes and reimbursement records (2016 to 2020).

Results

Patients with baseline FLI of 30 to 59.9 had a 1.90-fold higher risk (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularDiabetes Mellitus, Type 2Liver NeoplasmsNon-alcoholic Fatty Liver DiseaseHumansMiddle AgedMaleFemaleAdultAgedRisk FactorsPrognosisFollow-Up StudiesBody Mass IndexRetrospective StudiesLiver Cirrhosis

Stichwörter der Autor:innen

Carcinoma, hepatocellularDiabetes mellitus, type 2Non-alcoholic fatty liver diseaseRisk

Autor:innen und Institutionen

  • Department of Internal Medicine, Kangwon National University School of Medicine, Chuncheon, Korea.
  • Department of Medical Informatics, Jeonbuk National University Medical School, Jeonju, Korea.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.
  • Research Institute of Clinical Medicine, Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Korea.
  • Department of Medicine, Jeonbuk National University Graduate School, Jeonju, Korea.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.

Förderung

  • National Research Foundation of Korea
  • Ministry of Education

Zitieren

APA

Cho, E. H., Kang, M. G., Lee, C. H., Oh, S., Shen, C., Oh, H. R., Park, Y. R., Lee, H., Kim, J. S., & Park, J. H. (2025). Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2024.2286

Vancouver

Cho EH, Kang MG, Lee CH, Oh S, Shen C, Oh HR, et al. Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers. Endocrinology and Metabolism. 2025. doi:10.3803/enm.2024.2286

BibTeX
@article{Cho2025,
  author = {Cho, Eun-Hee and Kang, Min Gu and Lee, Chang Hun and Oh, Shinyoung and Shen, Chen and Oh, Ha Ram and Park, Young Ran and Lee, Hyun and Kim, Jong Seung and Park, Ji Hyun},
  title = {Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  doi = {10.3803/enm.2024.2286}
}
Kostenlos starten →